|
Mr. Gould, 67, was the Chief Patent Counsel and Vice President of Licensing and Corporate Development at Hoffmann-La Roche from 1989 to 1996. Since 1989, Mr. Gould has also been a Director of Protein Design Labs, Inc. (NASD: PDLI), a biotechnology company engaged in the development of humanized monoclonal antibodies for the prevention and treatment of disease. The company has a current market capitalization of $3.4 billion. Since 1996, Mr. Gould has taught patent law at Seton Hall University Law School and has been of counsel to the law firm of Gibbons, DelDeo, Dolan, Griffinger & Vecchione. Mr. Gould has degrees in chemistry from Johns Hopkins University and law degrees from Columbia University and New York University.
| 